Aclaris Therapeutics(ACRS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ACRS Aclaris Therapeutics

交易中 07-22 14:20:32 EDT

1.32

+0.00

0.00%

最高1.40	最低1.31	成交量39.01万
今开1.32	昨收1.32	日振幅6.44%
总市值9,407万	流通市值7,390万	总股本7,126万
成交额52.94万	换手率0.70%	流通股本5,599万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ACRS","market":"US","secType":"STK","nameCN":"Aclaris Therapeutics","latestPrice":1.32,"timestamp":1721672414785,"preClose":1.32,"halted":0,"volume":390119,"delay":0,"floatShares":55988502,"shares":71264786,"eps":-1.092844,"marketStatus":"交易中","marketStatusCode":2,"change":0,"latestTime":"07-22 14:20:32 EDT","open":1.32,"high":1.395,"low":1.31,"amount":529432.4064831,"amplitude":0.064394,"askPrice":1.33,"askSize":1100,"bidPrice":1.32,"bidSize":2474,"shortable":3,"etf":0,"ttmEps":-1.092844,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721678400000},"adr":0,"listingDate":1444190400000,"adjPreClose":1.32,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.3005,"preClose":1.32,"latestTime":"09:27 EDT","volume":4483,"amount":5819.6499351,"timestamp":1721654828374},"postHourTrading":{"tag":"盘后","latestPrice":1.3,"preClose":1.32,"latestTime":"19:39 EDT","volume":2752,"amount":3594.1756,"timestamp":1721432371358},"volumeRatio":0.316845,"impliedVol":1.1389,"impliedVolPercentile":0.3984},"requestUrl":"/m/hq/s/ACRS","defaultTab":"news","newsList":[{"id":"2453793054","title":"Aclaris Therapeutics, Inc.盘中异动 早盘股价大涨5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453793054","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453793054?lang=zh_cn&edition=full","pubTime":"2024-07-22 21:54","pubTimestamp":1721656496,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日21时54分，Aclaris Therapeutics, Inc.股票出现异动，股价大幅拉升5.49%。Aclaris Therapeutics, Inc.股票所在的生命科学行业中，整体涨幅为1.58%。其相关个股中，Star Equity Holdings Inc Cum Perpetual Pfd Ser A、Bioaffinity Technologies, Inc.、Aclaris Therapeutics, Inc.涨幅较大，Personalis, Inc.、Ispecimen Inc.、Endra Life Sciences Inc.较为活跃，换手率分别为2.31%、1.36%、0.94%，振幅较大的相关个股有T2 Biosystems, Inc.、Mainz Biomed N.V.、Personalis, Inc.，振幅分别为10.45%、9.74%、8.05%。Aclaris Therapeutics, Inc.公司简介：Aclaris Therapeutics Inc 是一家在美国运营的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222154569681ee72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222154569681ee72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","ACRS","BK4139"],"gpt_icon":0},{"id":"2452840139","title":"Aclaris Therapeutics(ACRS)盘前涨超10% 出售OLUMIANt专利权","url":"https://stock-news.laohu8.com/highlight/detail?id=2452840139","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452840139?lang=zh_cn&edition=full","pubTime":"2024-07-17 18:03","pubTimestamp":1721210594,"startTime":"0","endTime":"0","summary":"金吾财讯 | Aclaris Therapeutics(ACRS)盘前涨超10%，截至发稿，报1.48美元。消息面上，aclaris therapeutics宣布向omers life sciences出售OLUMIANt专利权和里程碑，最高可达3150万美元。","market":"us","thumbnail":"https://static.szfiu.com/news/20210625/NWUyOTcwN2U1MzQ2YjViNjMyZDcwZGM2MmQ0YzE5MjMxNzMwNDc5NDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NWUyOTcwN2U1MzQ2YjViNjMyZDcwZGM2MmQ0YzE5MjMxNzMwNDc5NDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"277875","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ACRS","BK4139","BK4007"],"gpt_icon":0},{"id":"2433723441","title":"BUZZ-Aclaris Therapeutics 因第一季度收入下降而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2433723441","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433723441?lang=zh_cn&edition=full","pubTime":"2024-05-08 20:46","pubTimestamp":1715172412,"startTime":"0","endTime":"0","summary":"    5月8日 - ** 药物开发商 Aclaris Therapeutics    股价盘前下跌 5.9% 至 1.26 美元 ** 该公司周二晚些时候公布的第一季度收入为240万美元，去年同期为253万美元 ** 截至 2024 年 3 月 31 日，公司拥有现金、现金等价物和有价证券 1.614 亿美元，而截至 2023 年 12 月 31 日为 1.819 亿美元。** 公司表示，第一季度的大部分现金支出与终止研发项目和之前宣布的裁员有关， 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LENZ","BK4007","ACRS","BUZZ"],"gpt_icon":0},{"id":"2433675883","title":"Aclaris Therapeutics Inc 报告截至一月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2433675883","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433675883?lang=zh_cn&edition=full","pubTime":"2024-05-08 05:02","pubTimestamp":1715115778,"startTime":"0","endTime":"0","summary":"   * Aclaris Therapeutics Inc   报告，截至1月底的季度调整后每股亏损24美分，高于去年同期的每股-40美分。八位分析师对该季度的平均预期是每股亏损 29 美分。华尔街预期为每股-37美分至-8美分。* 营收为 240 万美元，同比下降 5.1%；分析师预期为 137 万美元。* Aclaris Therapeutics Inc公布的本季度每股收益为亏损24美分。* 该公司当季亏损 1694 万美元。* Aclaris Therapeutics Inc的股价本季度上涨了5.6%，今年迄今为止上涨了24.8%。* 华尔街对 Aclaris Therapeutics Inc 的 12 个月目标价中位数为 2.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ACRS","BK4007","BK4139"],"gpt_icon":0},{"id":"2432157843","title":"Aclaris Therapeutics Inc    预计每股亏损 29 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432157843","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432157843?lang=zh_cn&edition=full","pubTime":"2024-05-04 08:18","pubTimestamp":1714781891,"startTime":"0","endTime":"0","summary":"   * Aclaris Therapeutics Inc    将于5月7日公布截至2024年3月31日的季度业绩报告，预计该公司的季度收入将出现下降。* 根据LSEG的数据，6位分析师的平均预期显示，这家总部位于宾夕法尼亚州韦恩市的公司预计营收将从去年同期的253万美元下降45.9%，至136.7万美元。* LSEG 分析师对 Aclaris Therapeutics Inc 的平均预期是每股亏损 29 美分。* 华尔街对 Aclaris Therapeutics Inc 的 12 个月目标价中位数为 2.00 美元，高于其上次收盘价 1.36 美元。5月4日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACRS","LENZ"],"gpt_icon":0},{"id":"2412733136","title":"Aclaris Therapeutics Inc    预计每股亏损 34 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2412733136","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2412733136?lang=zh_cn&edition=full","pubTime":"2024-02-19 22:06","pubTimestamp":1708351568,"startTime":"0","endTime":"0","summary":"   * Aclaris Therapeutics Inc    预计将在2月21日公布截至2023年12月31日的业绩报告时显示季度收入下降(预计)    * 根据LSEG的数据，8位分析师的平均预期显示，这家总部位于宾夕法尼亚州韦恩市的公司预计营收将从去年同期的775万美元下降56.6%，至336.3万美元。* LSEG 分析师对 Aclaris Therapeutics Inc 的平均预期是每股亏损 34 美分。* 华尔街对 Aclaris Therapeutics Inc 的 12 个月目标价中位数为 2.00 美元，高于其上一次收盘价 1.19 美元。2月19日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACRS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aclaristx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.1681},{"period":"3month","weight":0.0645},{"period":"6month","weight":0.1579},{"period":"1year","weight":-0.8736},{"period":"ytd","weight":0.2571}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aclaris Therapeutics, Inc.于2012年7月在美国特拉华州成立。该公司是一家临床阶段的生物制药公司，专注于开发免疫炎症疾病的新型候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.159429},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.00511},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.035243},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.000298},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.054521},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.002463},{"month":7,"riseRate":0.555556,"avgChangeRate":0.000483},{"month":8,"riseRate":0.5,"avgChangeRate":-0.042275},{"month":9,"riseRate":0.5,"avgChangeRate":0.038413},{"month":10,"riseRate":0.25,"avgChangeRate":0.052818},{"month":11,"riseRate":0.222222,"avgChangeRate":-0.060376},{"month":12,"riseRate":0.777778,"avgChangeRate":0.149317}],"exchange":"NASDAQ","name":"Aclaris Therapeutics","nameEN":"Aclaris Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aclaris Therapeutics(ACRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aclaris Therapeutics(ACRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aclaris Therapeutics,ACRS,Aclaris Therapeutics股票,Aclaris Therapeutics股票老虎,Aclaris Therapeutics股票老虎国际,Aclaris Therapeutics行情,Aclaris Therapeutics股票行情,Aclaris Therapeutics股价,Aclaris Therapeutics股市,Aclaris Therapeutics股票价格,Aclaris Therapeutics股票交易,Aclaris Therapeutics股票购买,Aclaris Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aclaris Therapeutics(ACRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aclaris Therapeutics(ACRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}